1869-6953

Diabetes Therapy

Springer-Verlag

View prefix report (10.1007)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1870 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1870 DOIs
2

Attach ORCID iDs across 888 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact888 DOIs
3

Deposit reference lists for 94 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact94 DOIs

DOIs for this ISSN

Showing the top 5 of 1888 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Adherence to Therapies in Patients with Type 2 Diabetes (10.1007/s13300-013-0034-y)
Abstract ORCID
137.10 551
2 Flash Glucose-Sensing Technology as a Replacement for Blood… (10.1007/s13300-016-0223-6)
Abstract ORCID
136.46 535
3 Management of Diabetic Foot Ulcers (10.1007/s13300-012-0004-9)
Abstract ORCID
128.87 377
4 A Practical Review of C-Peptide Testing in Diabetes (10.1007/s13300-017-0265-4)
Abstract ORCID
128.23 366
5 Effectiveness and Safety of a Novel Care Model for the Manag… (10.1007/s13300-018-0373-9)
Abstract ORCID
127.51 354
6 Diabetes Dyslipidemia (10.1007/s13300-016-0167-x)
Abstract ORCID
124.07 302
7 Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review… (10.1007/s13300-014-0089-4)
Abstract ORCID
121.33 266
8 Quantitative PCR tissue expression profiling of the human SG… (10.1007/s13300-010-0006-4)
Abstract ORCID
120.83 260
9 Prevalence and Risk Factors for Diabetes Mellitus in Nigeria… (10.1007/s13300-018-0441-1)
Abstract ORCID
120.24 253
10 Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfuncti… (10.1007/s13300-017-0355-3)
Abstract ORCID License
115.81 34
11 A View Beyond HbA1c: Role of Continuous Glucose Monitoring (10.1007/s13300-019-0619-1)
Abstract ORCID
113.71 187
12 Drug Therapy in Obesity: A Review of Current and Emerging Tr… (10.1007/s13300-020-00816-y)
Abstract ORCID
112.03 173
13 Utility and Limitations of Glycated Hemoglobin (HbA1c) in Pa… (10.1007/s13300-017-0362-4)
Abstract ORCID License
111.85 30
14 Effects of Acarbose on the Gut Microbiota of Prediabetic Pat… (10.1007/s13300-017-0226-y)
Abstract ORCID
111.78 171
15 Use of Flash Glucose-Sensing Technology for 12 months as a R… (10.1007/s13300-017-0255-6)
Abstract ORCID
111.78 171
16 The Impact of Flash Glucose Monitoring on Glycaemic Control… (10.1007/s13300-019-00720-0)
Abstract ORCID
109.66 155
17 Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a N… (10.1007/s13300-019-00743-7)
Abstract ORCID
108.66 148
18 Diabetic Gastroparesis: Principles and Current Trends in Man… (10.1007/s13300-018-0454-9)
Abstract ORCID
107.77 142
19 Treatment Options for MODY Patients: A Systematic Review of… (10.1007/s13300-020-00864-4)
Abstract ORCID
107.15 138
20 Diabetic Neuropathy and Gait: A Review (10.1007/s13300-017-0295-y)
Abstract ORCID
106.52 134
21 Ertugliflozin in Patients with Stage 3 Chronic Kidney Diseas… (10.1007/s13300-017-0337-5)
Abstract License
106.36 133
22 Skin Autofluorescence is a Noninvasive Surrogate Marker for… (10.1007/s13300-017-0339-3)
Abstract ORCID License
106.12 25
23 Cardiovascular Risk in Type 1 Diabetes Mellitus (10.1007/s13300-019-0612-8)
Abstract ORCID
104.85 124
24 The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combi… (10.1007/s13300-016-0218-3)
Abstract ORCID
104.67 123
25 Hypoglycemia Event Rates: A Comparison Between Real-World Da… (10.1007/s13300-016-0157-z)
Abstract ORCID
103.41 116
26 Incretin-based therapy: a powerful and promising weapon in t… (10.1007/s13300-011-0002-3)
Abstract ORCID
103.03 114
27 Smartphone-Based Technology in Diabetes Management (10.1007/s13300-020-00768-3)
Abstract ORCID
103.03 114
28 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics… (10.1007/s13300-013-0030-2)
Abstract ORCID
101.67 107
29 Safety and Tolerability of Sitagliptin in Type 2 Diabetes: P… (10.1007/s13300-013-0024-0)
Abstract ORCID
100.85 103
30 Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening… (10.1007/s13300-019-00700-4)
Abstract ORCID
100.22 100
31 Resistance Training for Glycemic Control, Muscular Strength,… (10.1007/s13300-017-0258-3)
Abstract ORCID
99.78 98
32 Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitor… (10.1007/s13300-014-0061-3)
Abstract ORCID
99.56 97
33 Diabetes Distress or Major Depressive Disorder? A Practical… (10.1007/s13300-017-0231-1)
Abstract ORCID
98.19 91
34 A Systematic Review of the Direct Economic Burden of Type 2… (10.1007/s13300-015-0096-0)
Abstract ORCID
97.22 87
35 Comparison Review of Short-Acting and Long-Acting Glucagon-l… (10.1007/s13300-015-0127-x)
Abstract ORCID
96.98 86
36 Adherence to Medication, Diet and Physical Activity and the… (10.1007/s13300-019-00750-8)
Abstract ORCID
96.98 86
37 Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Tar… (10.1007/s13300-013-0042-y)
Abstract ORCID
95.69 81
38 SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence… (10.1007/s13300-018-0471-8)
Abstract ORCID
95.15 79
39 Movement is Improvement: The Therapeutic Effects of Exercise… (10.1007/s13300-021-01005-1)
Abstract ORCID
94.88 78
40 Ertugliflozin and Sitagliptin Co-initiation in Patients with… (10.1007/s13300-017-0358-0)
Abstract License
94.60 77
41 The Do-It-Yourself Artificial Pancreas: A Comprehensive Revi… (10.1007/s13300-020-00823-z)
Abstract ORCID
94.60 77
42 Insulin Degludec Versus Insulin Glargine in Type 1 and Type… (10.1007/s13300-014-0076-9)
Abstract ORCID
94.32 76
43 Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis (10.1007/s13300-017-0273-4)
Abstract ORCID
94.32 76
44 Patient Perceptions and Preferences for a Mealtime Insulin D… (10.1007/s13300-017-0365-1)
Abstract ORCID License
94.15 17
45 Post-Liver Transplantation Diabetes Mellitus: A Review of Re… (10.1007/s13300-018-0374-8)
Abstract ORCID
94.04 75
46 Clinical Effectiveness of Liraglutide in Type 2 Diabetes Tre… (10.1007/s13300-016-0180-0)
Abstract ORCID
93.17 72
47 Empagliflozin Induces Transient Diuresis Without Changing Lo… (10.1007/s13300-018-0385-5)
Abstract ORCID
93.17 72
48 The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 In… (10.1007/s13300-019-00686-z)
Abstract ORCID
92.87 71
49 The management of diabetic ketoacidosis in children (10.1007/s13300-010-0008-2)
Abstract ORCID
92.56 70
50 Management of Type 2 Diabetes in Developing Countries: Balan… (10.1007/s13300-019-00733-9)
Abstract ORCID
92.25 69